17 November 2026 : Original article
Return to Alcohol Use After Liver Transplant: Who Is at Risk?
Sienna D. Lila BCDEF 1*, Kelly C. Hsu BC 2, Katherine C. SpechtDOI: 10.12659/AOT.952998
Ann Transplant 2026; 31:e952998
Abstract
BACKGROUND: Alcohol-associated liver disease remains the leading indication for liver transplant (LT), yet there has been limited analysis of what psychosocial factors correlate with biomarker-confirmed return to alcohol use in the post-LT setting.
MATERIAL AND METHODS: We conducted a single-center, retrospective, cohort study of all adult patients with alcohol-associated liver disease who received a liver transplant (LT) between 2016 and 2022. Medical records were queried for demographics, psychosocial variables, pre-LT sobriety duration, and 1-year post-LT mortality. Logistic regression and time-to-event analysis was used to correlate these factors with post-LT biomarker-confirmed return to alcohol use, defined as at least 1 positive urine ethyl glucuronide, urine ethyl sulfate, or serum phosphatidylethanol.
RESULTS: Of 194 LT recipients, 52 (27% of all patients, 42% of those tested) tested positive for 1 or more alcohol biomarkers at least once. Female sex and younger age, but not pre-LT sobriety duration, were identified as independent risk factors for biomarker-confirmed post-LT return to alcohol use. Survival analysis identified a shorter time to biomarker confirmed return to alcohol use for patients with <6 months (P<0.0001) and 6-12 months (P<0.0001) of pre-LT sobriety, compared with those with ≥12 months sobriety. However, patients with shorter pre-LT sobriety duration underwent biomarker testing significantly earlier following LT (P<0.0001). There was no difference in 1-year post-LT mortality between patients with <6 months and those with > 6-month pre-LT sobriety.
CONCLUSIONS: In this retrospective cohort study, we observed that 1-year mortality and biomarker-confirmed return to alcohol use outcomes were not affected by pre-LT sobriety duration, supporting evolving standards that favor individualized risk assessment over fixed abstinence periods.
Keywords: Alcohol Abstinence, Alcohol Drinking, Alcohol-Related Disorders, biomarkers, Liver, Mortality, Transplantation
Most Viewed Current Articles
24 Aug 2021 : Review article 22,545
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
29 Sep 2015 : Review article 18,912
Risk Factors for Chronic Renal Insufficiency Following Cardiac TransplantationDOI :10.12659/AOT.893788
Ann Transplant 2015; 20:576-587
29 Dec 2021 : Original article 18,710
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
22 Nov 2022 : Original article 17,291
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988






